Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-05-24 @ 11:56 AM
Study NCT ID:
NCT05189067
Status:
UNKNOWN
Last Update Posted:
2022-01-12
First Post:
2021-12-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer
Sponsor:
Organization: